
Persica’s antibiotic-based drug alleviates lower back pain in Phase Ib trial
Persica Pharmaceuticals will advance its antibiotic-based drug to registrational studies after a Phase Ib study found that the therapy alleviated lower back pain in patients. The UK-based biotech said that the trial (NCT04238676) of PP353, a novel, non- …